2026 Best Value Clinical and Industrial Drug Development Schools in the Far Western Region
[Clinical and Industrial Drug Development](/majors/health-care-professions/pharmacy-pharmaceutical-sciences/clinical-and-industrial-drug-development/) programs reward a close look at where your money goes furthest. A high-value program keeps cost low while graduates go on to earn well.
To produce this 2026 ranking, College Factual evaluated 3 schools on the balance of cost and outcomes for clinical and industrial drug development students.
What’s on this page:
2026 Best Value Clinical and Industrial Drug Development Schools in the Far Western Region
If you want to know which schools deliver the best value for the clinical and industrial drug development degrees they offer, see the list below.
Best Value Clinical and Industrial Drug Development Schools
Our analysis ranked University Of California San Diego the best value for a degree in clinical and industrial drug development in the Far Western Region. Located in the city of La Jolla, University Of California San Diego is a very large public university. The average in-state cost of tuition and fees is $15,788, compared with $47,676 for out-of-state students. Typical student debt for clinical and industrial drug development graduates is $17,101. Early-career clinical and industrial drug development graduates make about $113,226. Set against $17,101 in median debt, that is a healthy payoff. University Of California San Diego admits about 27% of applicants.
University Of Washington Seattle Campus came in at #2 on our 2026 list of the best value clinical and industrial drug development schools. Located in the city of Seattle, University Of Washington Seattle Campus is a very large public university. Expect in-state tuition and fees of around $12,973, compared with $43,209 for out-of-state students. Typical student debt for clinical and industrial drug development graduates is $16,481. Early-career clinical and industrial drug development graduates make about $109,852. Weighed against typical debt, the earnings make a compelling case for value. The acceptance rate is 39%.
University Of Southern California is a great value for students pursuing a degree in clinical and industrial drug development, landing the #3 spot this year. Set in the city of Los Angeles, University Of Southern California is a very large private not-for-profit institution. In-state tuition and fees average $71,647. Students borrow a median of $15,625 to complete the clinical and industrial drug development program here. Early-career clinical and industrial drug development graduates make about $114,101. That is a strong return on a $15,625 median debt. University Of Southern California admits about 10% of applicants.
Narrow Clinical and Industrial Drug Development Schools by State
More Clinical and Industrial Drug Development Rankings
View All Clinical and Industrial Drug Development Rankings >
Notes and References
This ranking is produced by College Factual (MF_RANKING_2025), 2026 edition. The methodology weighs the cost of a degree against the earnings graduates go on to achieve, drawn primarily from the U.S. Department of Education (IPEDS and College Scorecard).
Ranking method: College Major Best Value · 3 schools evaluated.
*Averages shown above reflect the top 3 ranked schools only.
- The Integrated Postsecondary Education Data System (IPEDS) from the National Center for Education Statistics (NCES), a branch of the U.S. Department of Education (DOE), serves as the core of our data about colleges.
- Some other college data, including much of the graduate earnings data, comes from the U.S. Department of Education’s (College Scorecard).
More about our data sources and methodologies.
